REVIEW article
Front. Pharmacol.
Sec. Pharmacology of Anti-Cancer Drugs
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1579183
This article is part of the Research TopicUnlocking Autophagy’s Full Potential: Embracing a Multidimensional Approach for Targeted Cancer TreatmentView all 5 articles
Autophagy as a Potential Therapeutic Target in Regulating Improper Cellular Proliferation
Provisionally accepted- 1Indian Institute of Technology Jodhpur, Jodhpur, India
- 2University of Delhi, New Delhi, National Capital Territory of Delhi, India
- 3Birla Institute of Technology and Science, Pilani, Rajasthan, India
- 4National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India
- 5Institute of Nano Science and Technology (INST), Mohali, Punjab, India
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Autophagy is a degradative process that makes rapid turnover of old and impaired proteins and organelles possible. It is highly instigated by stress signals, like starvation, and contributes to the cell's homeostasis. Autophagy performs a crucial function in keeping cell genomic integrity stable. Impaired autophagic flux is implicated in neurodegenerative diseases, abnormal ageing, and cancerous diseases. In diseases like cancer, autophagy performs a dualistic function; it can have both a tumor-suppressive and supportive role. Autophagy in the initial phases of tumorigenesis maintains the integrity of the genome and, if it fails, leads to cell death, thus having a tumor-suppressive role. Meanwhile, autophagy also imparts the function of the pro-survival mechanism in the latter stages of tumorigenesis and supports the cancerous cells in surviving conditions like hypoxia and increased oxidative stress. Autophagy also helps cancerous cells develop drug resistance in some cases. Thus, modulation of the autophagic mechanism is a possible therapeutic strategy in cancer therapy as its inhibition can sensitise cancer cells to anticancerous drugs. The promotion of autophagy, in some cases, can also safeguard cells from toxic protein aggregation and enhanced oxidative stress. Excessive autophagy can result in autophagic cell death. Autophagy also regulates several cellular processes and cell death pathways, like apoptosis. Therefore, an in-depth knowledge of the autophagy process and its regulating molecules is critically important. Pharmaceutical small molecules or cellular target modulation can help modulate the cellular autophagy process in the context of specific disease conditions.
Keywords: Autophagy, autophagy inhibitors, Autophagy activators, Autophagy modulation Cancer, cancer therapeutics
Received: 18 Feb 2025; Accepted: 24 Apr 2025.
Copyright: © 2025 Kumar, Choudhary, Kinger, Jagtap, Prajapati, Chitkara, Chinnathamb, Verma, Mishra and Chinnathambi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Amit Mishra, Indian Institute of Technology Jodhpur, Jodhpur, India
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.